CUX1

(redirected from Clox)

CUX1

A gene on chromosome 7q22.1 that encodes a member of the homeodomain family of DNA binding proteins that may regulate gene expression, morphogenesis, differentiation and play a role in cell cycle progession.
Segen's Medical Dictionary. © 2012 Farlex, Inc. All rights reserved.
Mentioned in ?
References in periodicals archive ?
High frequency oscillations have been evaluated through a band pass filter between 1 and 20 kHz and centroid luminosity oscillations along x and y axes, CLOx and CLOy respectively, were obtained.
Green exhibited no sign of cognitive impairment using the Six-Item Screener (score: 6 out of 6) (Callahan, Unverzagt, Hui, Perkins, & Hendrie, 2002) and the Clock Drawing Executive Test (CLOX) assessment (an executive function clock drawing task) (Shulman, Gold, Cohen, & Zucchero, 1993).
Seo et al., "Functional neuroanatomical correlates of the executive clock drawing task (CLOX) performance in Alzheimer's disease: a FDG-PET study," Neuroscience, vol.
More fine grained cognitive assessment revealed mild impairment in executive functioning based on the CLOX (Royall, Cordes, & Polk, 1998) visual spatial performance and delayed recall were severely impaired, based on CERAD subtests (Morris, Heyman, & Mohs, 1989).
Como metodos de tamizaje de la funcion cognitiva se usaron el Mini-mental state examination (MMSE) (22) y el Clock Drawing Executive Test (CLOX) (23).
Antimicrobial susceptibility of the more common ([greater than or equal to]15 isolates) Gram-positive organisms Antimicrobial sensitivity n (%) Organism (number of isolates) Amp Clinda Clox Eryth S.
B vitamins stabilized executive function (CLOX) relative to placebo.
However, not all clock drawing tasks are necessarily "executive" and some, such as the Executive Clock Drawing Task (CLOX), correlate better with other putative executive measures such as the Executive Interview (EXIT25) [29-30].
A trend toward improvement on the clock drawing tests CLOX 1 and CLOX 2 scores--which measure executive cognitive function deficits and posterior cortical impairment, respectively--was also seen in the treatment group, compared with the placebo group, Dr.
Several cognitive domains were measured, including speed of processing (Useful Field of View [UFOV] and Complex Reaction Time), psychomotor speed and visuomotor coordination (Trails A, Finger Tapping Test, Digit Symbol Copy, and Digit Symbol Substitution), attention and working memory (Digit Span and Spatial Span), reasoning (Letter Comparison and Pattern Comparison), and executive functioning (Trails B, CLOX).